These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19287086)

  • 1. In vitro kinetic studies on the mechanism of oxygen-dependent cellular uptake of copper radiopharmaceuticals.
    Holland JP; Giansiracusa JH; Bell SG; Wong LL; Dilworth JR
    Phys Med Biol; 2009 Apr; 54(7):2103-19. PubMed ID: 19287086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectroelectrochemical and computational studies on the mechanism of hypoxia selectivity of copper radiopharmaceuticals.
    Holland JP; Barnard PJ; Collison D; Dilworth JR; Edge R; Green JC; McInnes EJ
    Chemistry; 2008; 14(19):5890-907. PubMed ID: 18494010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
    Bonnitcha PD; Bayly SR; Theobald MB; Betts HM; Lewis JS; Dilworth JR
    J Inorg Biochem; 2010 Feb; 104(2):126-35. PubMed ID: 19932509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of hypoxic selectivity in copper bis(thiosemicarbazone) radiopharmaceuticals.
    Maurer RI; Blower PJ; Dilworth JR; Reynolds CA; Zheng Y; Mullen GE
    J Med Chem; 2002 Mar; 45(7):1420-31. PubMed ID: 11906283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of copper between bis(thiosemicarbazone) ligands and intracellular copper-binding proteins. insights into mechanisms of copper uptake and hypoxia selectivity.
    Xiao Z; Donnelly PS; Zimmermann M; Wedd AG
    Inorg Chem; 2008 May; 47(10):4338-47. PubMed ID: 18412332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM.
    Dearling JL; Packard AB
    Nucl Med Biol; 2010 Apr; 37(3):237-43. PubMed ID: 20346863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
    Lewis JS; McCarthy DW; McCarthy TJ; Fujibayashi Y; Welch MJ
    J Nucl Med; 1999 Jan; 40(1):177-83. PubMed ID: 9935074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia imaging and theranostic potential of [
    Liu T; Karlsen M; Karlberg AM; Redalen KR
    EJNMMI Res; 2020 Apr; 10(1):33. PubMed ID: 32274601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of positron emission tomography hypoxia tracer uptake and tissue oxygenation via electrochemical modeling.
    Bowen SR; van der Kogel AJ; Nordsmark M; Bentzen SM; Jeraj R
    Nucl Med Biol; 2011 Aug; 38(6):771-80. PubMed ID: 21843774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
    Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
    J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
    Lewis JS; Herrero P; Sharp TL; Engelbach JA; Fujibayashi Y; Laforest R; Kovacs A; Gropler RJ; Welch MJ
    J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
    Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
    Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.
    Hueting R; Kersemans V; Cornelissen B; Tredwell M; Hussien K; Christlieb M; Gee AD; Passchier J; Smart SC; Dilworth JR; Gouverneur V; Muschel RJ
    J Nucl Med; 2014 Jan; 55(1):128-34. PubMed ID: 24337603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.
    Burgman P; O'Donoghue JA; Lewis JS; Welch MJ; Humm JL; Ling CC
    Nucl Med Biol; 2005 Aug; 32(6):623-30. PubMed ID: 16026709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper(I)-dioxygen reactivity of [(L)Cu(I)](+) (L = tris(2-pyridylmethyl)amine): kinetic/thermodynamic and spectroscopic studies concerning the formation of Cu-O2 and Cu2-O2 adducts as a function of solvent medium and 4-pyridyl ligand substituent variations.
    Zhang CX; Kaderli S; Costas M; Kim EI; Neuhold YM; Karlin KD; Zuberbühler AD
    Inorg Chem; 2003 Mar; 42(6):1807-24. PubMed ID: 12639113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.
    Obata A; Yoshimi E; Waki A; Lewis JS; Oyama N; Welch MJ; Saji H; Yonekura Y; Fujibayashi Y
    Ann Nucl Med; 2001 Dec; 15(6):499-504. PubMed ID: 11831397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
    Vāvere AL; Lewis JS
    Dalton Trans; 2007 Nov; (43):4893-902. PubMed ID: 17992274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects.
    Basken NE; Green MA
    Nucl Med Biol; 2009 Jul; 36(5):495-504. PubMed ID: 19520290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships.
    Dearling JL; Lewis JS; Mullen GE; Welch MJ; Blower PJ
    J Biol Inorg Chem; 2002 Mar; 7(3):249-59. PubMed ID: 11935349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.
    McQuade P; Martin KE; Castle TC; Went MJ; Blower PJ; Welch MJ; Lewis JS
    Nucl Med Biol; 2005 Feb; 32(2):147-56. PubMed ID: 15721760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.